Caladrius Biosciences announces 1-for-10 reverse split
Caladrius Biosciences announced a 1-for-10 reverse stock split of its outstanding common stock. The reverse stock split is intended to increase the per share trading price of the Company’s common stock to satisfy the NASDAQ $1.00 minimum bid price requirement. July 27, 2016